MSB 1.02% 99.0¢ mesoblast limited

Ann: MSB Q1 Financial Results and Operational Highlights, page-83

  1. 5,552 Posts.
    lightbulb Created with Sketch. 2021
    Just looked at NEJM policies. My guess is that the paper passed the "rapid peer review" which is not a guarantee of acceptance but probably as close as you can get before final approval.


    https://www.nejm.org/about-nejm/editorial-policies

    Rapid Peer Review

    Authors may request a Rapid Review of their manuscripts. NEJM generally replies to Rapid Review requests within three business days and an initial decision on publication will typically be reached within two weeks.

    Those studies that are most often approved for a rapid peer review generally:

    • Deal with urgent public health concerns
    • Have potential to dramatically change clinical practice or to affect mortality
    • Are timed to imminent meeting presentations

    Approval for Rapid Review does not guarantee acceptance of the manuscript, nor does it guarantee expedited publication if the manuscript is accepted as each of these decisions is made separately.

    https://www.nejm.org/media-center/publication-process

    Final Review & Acceptance for Publication

    The NEJM Editor-in-Chief reviews all final (revised) submissions and may raise further questions. The Editor-in-Chief is the only person who can officially accept a paper for publication. Following Dr. Rubin’s formal acceptance for publication, a paper will then move through rigorous processes for manuscript editing, production, illustration, design, and publication.

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
99.0¢
Change
0.010(1.02%)
Mkt cap ! $1.130B
Open High Low Value Volume
99.5¢ $1.02 98.5¢ $5.507M 5.501M

Buyers (Bids)

No. Vol. Price($)
1 9996 99.0¢
 

Sellers (Offers)

Price($) Vol. No.
99.5¢ 18069 3
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.